A pharmaceutical company is voluntarily recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical.
Torrent Pharmaceuticals Limited announced the recall for two lots of Losartan potassium tablets on the FDA (United States Food and Drug Administration) website.
The products contain trace amounts of N- nitrosodiethylamine (NDEA), and it really is a substance that does occur naturally in some specific foods, drinking water, air pollution, and industrial procedures, also has traditionally been classified as a probable human carcinogen depending on International Agency for Research on Cancer (IARC) classification.
Losartan is utilised to treat hypertension, and hypertensive patients with Left Ventricular Hypertrophy as well as for the treatment of nephropathy in Type 2 diabetic patients.
Patients who are on Losartan need to go on taking their drugs, officials claimed, since the risk of harm to this individual’s health may be greater if the procedure is stopped immediately without any alternative therapy.
Patients should contact their pharmacist or physician who is able to advise them about an alternative treatment before returning their medication, authorities explained.
These products subject to the recall are listed below and packaged in bottles. The item might be recognized by checking the product name manufacturer information, and batch or lot number in the bottle containing those services and products.